Navigation Links
Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
Date:5/18/2012

e chief hazard with Butrans.  Use with extreme caution in patients at risk of respiratory depression.
  • CNS Depression: Butrans may cause somnolence, dizziness, alterations in judgment and alterations in levels of consciousness, including coma.  Use with caution in patients who are receiving other central nervous system (CNS) depressants.  Additive CNS effects are expected when used with alcohol, benzodiazepines, other opioids, or illicit drugs.
  • QTc Prolongation: Avoid in patients with Long QT Syndrome, family history of Long QT Syndrome, or those taking Class IA or Class III antiarrhythmic medications.
  • Head Injury:  Butrans may worsen increased intracranial pressure and obscure its signs, such as level of consciousness or pupillary signs.
  • Hypotensive Effects: Butrans may cause severe hypotension.  Use with caution in patients at increased risk of hypotension and in patients in circulatory shock.
  • Application Site Skin Reactions: In rare cases, severe application site skin reactions with signs of marked inflammation including "burn," "discharge," and "vesicles" have occurred.
  • Anaphylactic/Allergic Reactions: Cases of acute and chronic hypersensitivity to buprenorphine have been reported both in clinical trials and in the post-marketing experience.
  • Use in Pancreatic/Biliary Tract Disease and Other Gastrointestinal Conditions: Use with caution in patients with biliary tract disease, including acute pancreatitis.  Ileus may occur.  Monitor for decreased bowel motility.
  • Adverse Event InformationThe most common adverse reactions (>5%) included: nausea, headache, application site pruritus, dizziness, constipation, somnolence, vomiting, application site erythema, dry mouth, and application site rash. 

    Butrans Transdermal System Dosages Three strengths of Butrans are commercially available by pre
    '/>"/>

    SOURCE Purdue Pharma L.P.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
    2. Purdue Pharma L.P. Provides Free Security Mobiles and Educational Safety Videos to Good Neighbor Pharmacy Members
    3. Purdue Pharma L.P. to Present Data From Clinical Program for Butrans™ (buprenorphine) Transdermal System CIII at PAINWeek® 2010
    4. NASCSA Receives $200,000 Grant From Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
    5. RxDrugSAFE™ Featured in National Campaign by Purdue Pharma and NCPA
    6. Purdue Pharma L.P. and the National Community Pharmacists Association Join Forces to Help Prevent Pharmacy Burglary
    7. Purdue Pharma L.P. Re-launches Partners Against Pain Website
    8. New Online Resource to Help Combat Abuse of Prescription Medications Launched by Purdue Pharma L.P.
    9. Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection
    10. NASCSA Receives $200,000 Grant from Purdue Pharma L.P. to Support State Prescription Drug Monitoring Programs
    11. NEA Health Information Network and Purdue Pharma L.P. Partner to Help Kids be Safe
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:3/31/2015)... March 31, 2015  On May 2, 2015 ... in Santa Monica, CA ... Therapies for Malignant Pleural Mesothelioma (MPM), a rare ... asbestos and commonly affects the lining of the ... UCLA and the Pacific Mesothelioma Center (PMC). ...
    (Date:3/31/2015)... Texas , March 31, 2015 MedSpring Urgent Care ... the Dallas/Fort-Worth area of Upper Greenville. The ... second Dallas location. Knox ... well received by the surrounding community since opening last fall. Additional ... open in the Keller and Las Colinas ...
    (Date:3/31/2015)... 31, 2015 Immune Pharmaceuticals Inc. ("Immune", the ... intends to expand its planned bullous pemphigoid (BP) clinical ... eotaxin-1. Bullous Pemphigoid is an orphan auto-immune blistering disease ... US and Europe . ... in a Phase II clinical trial in ...
    Breaking Medicine Technology:Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 2Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 3Cutting-Edge Research to Be Presented at 5th Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma in Santa Monica 4MedSpring Urgent Care Opens New Upper Greenville Location in Dallas 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 2Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 3Immune Pharmaceuticals To Expand Bullous Pemphigoid Clinical Development Plan For Bertilimumab 4
    (Date:3/31/2015)... (PRWEB) March 31, 2015 Due ... started to hire more caregivers, staffing personnel, and ... and care managers within the Greater Los Angeles ... training institution, 1Heart Caregiver University has firmed up ... its mission to provide quality in-home care through ...
    (Date:3/31/2015)... IL (PRWEB) March 31, 2015 As ... Chunk Fitness is pledging to have a mobile-friendly website ... This is part of Chunk Fitness’ continued commitment to ... its growing user base. All of the same great ... available; it will be substantially easier to read while ...
    (Date:3/31/2015)... VA (PRWEB) March 31, 2015 ... takes place from April 1-7, the Mesothelioma Applied ... its new prevention program, to complement its existing ... , “As part of the Meso Foundation’s ... extinguish fears of diseases related to asbestos, including ...
    (Date:3/31/2015)... 31, 2015 Calling all runners, walkers and ... other tick-borne diseases! The first annual “Lyme Walk & Run” ... in Stamford, CT. The event, hosted by Lyme Research ... raise funds to support research and education about Lyme and ... all ages and abilities, will feature 5K and 10K runs ...
    (Date:3/31/2015)... 2015 Indosoft, developer of the Q-Suite call ... in development of their 5.x line. The industry leading ... deployed around the world for more than a decade. By ... telephony platform, Q-Suite can fully embrace newer Asterisk features and ... software on Asterisk for more than a decade. The use ...
    Breaking Medicine News(10 mins):Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 2Health News:1Heart Ends 1st Quarter of the Year With 1Heart Caregiver University Training of New Staff and Commits To Provide More Jobs For Year 2015 3Health News:Mesothelioma Research Organization Announces New Prevention Program 2Health News:Mesothelioma Research Organization Announces New Prevention Program 3Health News:Lyme Research Alliance & Tick-Borne Disease Alliance to Kick-Off 1st “Lyme Walk & Run” Event, April 26 2Health News:Indosoft Announces End of Life for Asterisk 1.4 Support in Q-Suite 5 Call Center Software 2
    ... Mass., March 3 Indevus,Pharmaceuticals, Inc. (Nasdaq: IDEV ) ... Indevus, Chief Executive Officer and Chairman of,the Board of Directors ... Dr. Cooper said, "After 15 years at the helm ... the time is right for me to retire from this ...
    ... to 29, the U.S. National Academy of Sciences will hold ... be elected. ELECTION RESULTS will be available online at ... Reporters can register in advance to receive the list of ... held in the auditorium of the National Academy of Sciences ...
    ... watching television and playing computer video games has been ... and physicians trying to help those children lose pounds., ... effect of limiting those activities, however. , University at ... that by using a device that automatically restricted video-viewing ...
    ... key tips for parents to protect children from,unsafe ... passengers, ages,12 to 16, are more likely to ... to a study released today in the Archives ... each teenage year. Conducted,as part of an on-going ...
    ... without approval , , MONDAY, March 3 (HealthDay News) ... prescription drugs increases the risk of drug abuse, says ... McCabe asked 3,639 college students, average age 19.9 years, ... of prescription drugs -- opioids, stimulants, sleeping aids and ...
    ... but no such link for depression , , MONDAY, March 3 ... on a stroke may have merit, British researchers say. , ... to how severe their stress is, someone in the highest ... increased risk of stroke than someone in the lowest group," ...
    Cached Medicine News:Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 2Health News:Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman 3Health News:Annual meeting of the National Academy of Sciences 2Health News:Restricting kids' video time reduces obesity, randomized trial shows 2Health News:New Research Shows Car Crash Deaths Increase Starting At Age 12 2Health News:New Research Shows Car Crash Deaths Increase Starting At Age 12 3Health News:Non-Medical Use of Prescriptions Linked to Drug Abuse Risk 2Health News:Stress Can Help Trigger Stroke 2
    SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
    Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
    Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
    Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
    Medicine Products: